Locations:
Search IconSearch
June 28, 2022/News Updates

Cleveland Clinic Statement on Women’s Health

Job # 073575 Paladion 08-05-13

“Our strongly held conviction is that women’s healthcare decisions are best made between a patient and their healthcare provider — a relationship based on privacy and trust. It is a privilege for us to serve patients with such an intimate understanding of their lives.

We are deeply concerned about the consequences that restrictive abortion laws will have on women and families.

The United States already has among the poorest infant and maternal mortality rates in the developed world. Minority and low-income women in particular will be disproportionately affected by restrictions to reproductive healthcare, which were swiftly put into effect in Ohio.

We remain committed to the health and well-being of our communities and will continue to support women and reproductive health while also following the law.

In support of our patients and communities, our leaders are working on recommendations for improving access and removing barriers to contraception, guiding patients on interstate travel and developing partnerships with other health systems and organizations.

In support of our caregivers, we are reviewing how benefits under the Employee Health Plan may be expanded to cover out-of-state reproductive health services for all members.

This is continuing to evolve as we come to better understand the new law.”

Latest from the Newsroom

Logos of Cleveland Clinic and the Women’s Alzheimer’s Movement (WAM) at Cleveland Clinic

Leading Researchers and Advocates Honored by Maria Shriver and The Women’s Alzheimer’s Movement at Cleveland Clinic

Beri Ridgeway, M.D.

Cleveland Clinic Appoints Beri Ridgeway, M.D., as President of Cleveland Clinic London

Genediting Therapy Shows Success Against Severe Sickle Cell Disease

Gene Editing Therapy Shows Success Against Severe Sickle Cell Disease

Cleveland Clinic's Main Campus lobby

Mandel Foundation Donates $50 Million to Improve Access to Care at Cleveland Clinic

Blood pressure cuff

Experimental Monthly Injectable Reduces a Key Regulator of Blood Pressure

GLP-1 injection pen with a stethoscope

Tirzepatide Associated with Lower Risk of Heart and Kidney Damage Compared to Dulaglutide in Patients with Type 2 Diabetes and Cardiovascular Disease

Hospital Care At Home

Cleveland Clinic Introduces Hospital Care At Home in Ohio

Image of a scaled and tape measure

What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights